← All stocks

UroGen Pharma Ltd.

URGN Net selling
CIK 0001668243 #1945 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$4.73M
$1.30M on a plan · $179.68K straight out of an exercise
Sold at will
$3.25M
9 of 15 sales
Net
−$4.73M
−$3.25M against sales at will

By person

8 insiders · 15 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Schoenberg Mark
Chief Medical Officer
$4.48M (10)
−$4.48M
59,882
0.1225%
$2.55M
−58.7%
Smith Jason Drew
General Counsel
$211.88K (4)
−$211.88K
53,141
0.1087%
$2.26M
+110.7%
Degnan Chris
Chief Financial Officer
$37.12K (1) scheduled
−$37.12K
2,280
0.0047%
$96.99K
Robinson James A. Jr.
Director
8,000
0.0164%
$340.32K
WEN LEANA
Director
2,000
0.0041%
$85.08K
Wildman Daniel George
Director
2,000
0.0041%
$85.08K
Holden Stuart
Director
2,000
0.0041%
$85.08K
BUTITTA CYNTHIA M
Director
2,000
0.0041%
$85.08K
Insider
Date
Role
Action
Shares
Price
Amount
Smith Jason Drew
8 Sep 2026
General Counsel
Sell
1,519
$42.54
$64.62K
Schoenberg Mark
8 Sep 2026
Chief Medical Officer
Sell
871
$42.92
$37.38K
Schoenberg Mark
20 Aug 2026
Chief Medical Officer
Sell
60,677
$47.05
$2.85M
Schoenberg Mark
9 Jul 2026
Chief Medical Officer
Sold on a plan
10,000
$40.00
$400.00K
Schoenberg Mark
22 Jun 2026
Chief Medical Officer
Sold on a plan
10,000
$35.01
$350.10K
Schoenberg Mark
8 Jun 2026
Chief Medical Officer
Sold after exercise
5,222
$27.30
$142.56K
Schoenberg Mark
8 May 2026
Chief Medical Officer
Sold on a plan
10,000
$30.00
$300.00K
Schoenberg Mark
3 Feb 2026
Chief Medical Officer
Sell
3,686
$19.69
$72.58K
Schoenberg Mark
3 Feb 2026
Chief Medical Officer
Sell
1,843
$19.69
$36.29K
Schoenberg Mark
3 Feb 2026
Chief Medical Officer
Sell
1,844
$19.69
$36.31K
Smith Jason Drew
3 Feb 2026
General Counsel
Sell
3,217
$19.69
$63.34K
Smith Jason Drew
3 Feb 2026
General Counsel
Sell
1,608
$19.69
$31.66K
Smith Jason Drew
3 Feb 2026
General Counsel
Sell
2,654
$19.69
$52.26K
Schoenberg Mark
19 Nov 2025
Chief Medical Officer
Sold on a plan
10,000
$25.00
$250.00K
Degnan Chris
8 Oct 2025
Chief Financial Officer
Sold after exercise
2,203
$16.85
$37.12K

What was left out

Form 4 filings counted 28
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 2
Sales at will 9
Transactions with no price 0
Shares from compensation/vesting 62,317
History held since 29 Nov 2017